Sterling Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Buy
12,083
+10,487
+657% +$1.29M 0.03% 408
2026
Q1
$188K Sell
1,596
-1,180
-43% -$165K ﹤0.01% 1199
2025
Q4
$455K Sell
2,776
-86
-3% -$13.5K 0.01% 974
2025
Q3
$383K Sell
2,862
-217
-7% -$26.4K 0.01% 1087
2025
Q2
$383K Buy
3,079
+398
+15% +$50.6K 0.01% 1045
2025
Q1
$341K Sell
2,681
-301
-10% -$46.3K 0.01% 1026
2024
Q4
$429K Buy
2,982
+1,017
+52% +$146K 0.01% 1002
2024
Q3
$292K Buy
+1,965
New +$282K ﹤0.01% 1148
2013
Q3
Sell
-38,277
Closed -$315K 692
2013
Q2
$315K Buy
+38,277
New +$321K ﹤0.01% 477

Other funds holding RGEN

Sterling Capital Management's RGEN Position: Q2 2026 in Review

Sterling Capital Management increased its Repligen (RGEN) stake by 657% in Q2 2026, buying an estimated $1.29M and bringing the position to 12,083 shares worth $1.65M. The position accounts for 0.03% of the portfolio, ranked #408.

Sterling Capital Management first reported a position in RGEN in Q2 2013 and has held it in 9 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Sterling Capital Management held 12,083 shares of Repligen worth $1.65M as of Q2 2026.
  • Sterling Capital Management bought 10,487 Repligen shares in Q2 2026, an estimated $1.29M.
  • Repligen made up 0.03% of Sterling Capital Management's portfolio in Q2 2026, its #408 holding.
  • Sterling Capital Management first reported a position in Repligen in Q2 2013 and has held it in 9 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.